• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测甲状腺乳头状癌跳跃性转移的列线图。

A nomogram to predict skip metastasis in papillary thyroid cancer.

机构信息

General Surgery Department, Xiangya Hospital, Central South University, No.87 Xiangya Road, Changsha, 410008, China.

Department of Colorectal & Anal Surgery, Hepatobiliary & Enteric Surgery Rearch Center, Xiangya Hospital, Central South University, No.87 Xiangya Road, Changsha, 410008, Hunan Province, China.

出版信息

World J Surg Oncol. 2020 Jul 15;18(1):167. doi: 10.1186/s12957-020-01948-y.

DOI:10.1186/s12957-020-01948-y
PMID:32669128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7366301/
Abstract

BACKGROUND

Skip metastases are defined as lateral lymph node metastasis (LNM) without the involvement of central LNM in papillary thyroid cancer (PTC), and it is difficult to predict in clinical practice. Our study aimed to investigate the risk factors of skip metastasis and establish a nomogram for predicting the probability of skip metastasis in PTC patients.

PATIENTS AND METHODS

A total of 378 consecutive PTC patients with clinically suspected LNM who underwent modified radical neck dissection (MRND) from March 2018 to July 2019 in our hospital were enrolled. Univariate and multivariate analyses were used to examine risk factors of skip metastasis, and a nomogram prediction model was established and internally validated.

RESULTS

The incidence of skip metastases was 11.6% (44/378). Primary tumor size of ≤ 1 cm (OR = 2.703; 95% CI, 1.342-5.464; P = 0.005), age (OR = 1.051; 95% CI, 1.017-1.805; P = 0.005), and primary tumor location in the upper portion (OR = 6.799; 95% CI, 2.710-17.060; P < 0.001) were found to be independent risk factors for skip metastasis in PTC patients. A nomogram based upon these predictors performed well. The area under the curve (AUC) was 0.806 (95% CI, 0.736-0.876), and the P value of the Hosmer-Lemeshow goodness of fit test was 0.66. Decision curve analysis revealed that the nomogram was clinically useful.

CONCLUSION

Based on the risk factors of skip metastasis, a high-performance nomogram was established, which can provide an individual risk assessment and can guide treatment decisions for patients.

摘要

背景

甲状腺乳头状癌(PTC)中无中央区淋巴结转移(CLNM)的侧区淋巴结转移(SLNM)被定义为跳跃性转移(SMS),但在临床实践中难以预测。本研究旨在探讨 PTC 患者 SMS 的危险因素,并建立预测 PTC 患者 SMS 概率的列线图。

患者和方法

回顾性分析 2018 年 3 月至 2019 年 7 月我院收治的 378 例临床疑似颈侧区淋巴结转移(CLNM)且接受改良根治性颈淋巴结清扫术(MRND)的 PTC 患者。采用单因素和多因素分析来探讨 SMS 的危险因素,并建立和内部验证列线图预测模型。

结果

SMS 的发生率为 11.6%(44/378)。原发肿瘤直径≤1cm(OR=2.703;95%CI,1.342-5.464;P=0.005)、年龄(OR=1.051;95%CI,1.017-1.805;P=0.005)和肿瘤位于上极(OR=6.799;95%CI,2.710-17.060;P<0.001)是 PTC 患者发生 SMS 的独立危险因素。基于这些预测因素的列线图表现良好,曲线下面积(AUC)为 0.806(95%CI,0.736-0.876),Hosmer-Lemeshow 拟合优度检验的 P 值为 0.66。决策曲线分析显示,该列线图具有临床应用价值。

结论

基于 SMS 的危险因素,建立了一个高性能的列线图,可以为患者提供个体化风险评估,并指导治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/891bc936de29/12957_2020_1948_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/f8ef4674ba0d/12957_2020_1948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/e71ae6eb8f3c/12957_2020_1948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/56d0873a012f/12957_2020_1948_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/891bc936de29/12957_2020_1948_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/f8ef4674ba0d/12957_2020_1948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/e71ae6eb8f3c/12957_2020_1948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/56d0873a012f/12957_2020_1948_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48c/7366301/891bc936de29/12957_2020_1948_Fig4_HTML.jpg

相似文献

1
A nomogram to predict skip metastasis in papillary thyroid cancer.用于预测甲状腺乳头状癌跳跃性转移的列线图。
World J Surg Oncol. 2020 Jul 15;18(1):167. doi: 10.1186/s12957-020-01948-y.
2
A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.一种用于筛选甲状腺乳头状癌中阴性中央淋巴结转移患者跳跃转移的特定预测模型。
Front Endocrinol (Lausanne). 2021 Sep 30;12:743900. doi: 10.3389/fendo.2021.743900. eCollection 2021.
3
Comprehensive analysis of clinicopathologic and sonographic features in thyroid cancer with skip lymph node metastasis: establish and assessment of a prediction nomogram.甲状腺癌跳跃性淋巴结转移的临床病理及超声特征综合分析:预测列线图的建立与评估。
Braz J Otorhinolaryngol. 2023 Sep-Oct;89(5):101301. doi: 10.1016/j.bjorl.2023.101301. Epub 2023 Aug 3.
4
Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.甲状腺乳头状癌侧颈淋巴结跳跃转移的危险因素及预测模型。
World J Surg. 2020 May;44(5):1498-1505. doi: 10.1007/s00268-019-05332-0.
5
Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.用于预测有淋巴结转移高风险的 cN0 期甲状腺乳头状癌患者隐匿性转移的列线图。
Adv Clin Exp Med. 2023 Jul;32(7):753-761. doi: 10.17219/acem/157240.
6
Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.基于临床和超声特征预测甲状腺乳头状癌侧颈部淋巴结跳跃转移。
Front Endocrinol (Lausanne). 2023 May 9;14:1151505. doi: 10.3389/fendo.2023.1151505. eCollection 2023.
7
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.甲状腺乳头状癌跳跃性转移和侧颈部淋巴结转移的危险因素。
Surgery. 2019 Jul;166(1):55-60. doi: 10.1016/j.surg.2019.01.025. Epub 2019 Mar 12.
8
Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.甲状腺乳头状癌跳过中央颈部区域发生侧方淋巴结转移。
Oncotarget. 2017 Apr 18;8(16):27022-27033. doi: 10.18632/oncotarget.15388.
9
Risk factors of skip lateral lymph node metastasis in papillary thyroid carcinoma.甲状腺乳头状癌跳跃性侧颈淋巴结转移的危险因素。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):493-498. doi: 10.1007/s00405-020-06176-4. Epub 2020 Jun 30.
10
Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.构建并验证经典型甲状腺乳头状癌颈淋巴结转移预测列线图。
J Endocrinol Invest. 2021 Oct;44(10):2203-2211. doi: 10.1007/s40618-021-01524-5. Epub 2021 Feb 14.

引用本文的文献

1
A predictive model using platelets and neutrophil-to-lymphocyte ratio for the number of lymph node metastases in papillary thyroid carcinoma: a retrospective analysis.一项使用血小板和中性粒细胞与淋巴细胞比值预测甲状腺乳头状癌淋巴结转移数量的模型:一项回顾性分析
Gland Surg. 2025 Jul 31;14(7):1283-1294. doi: 10.21037/gs-2025-119. Epub 2025 Jul 28.
2
Predicting the Unexpected: Clinicopathological Insights into Skip Metastasis in Papillary Thyroid Carcinoma.预测意外情况:甲状腺乳头状癌跳跃转移的临床病理见解
J Clin Med. 2025 Jun 15;14(12):4255. doi: 10.3390/jcm14124255.
3
A Clinical Nomogram to Predict Survival Outcomes in Patients with Well-Differentiated Thyroid Cancer.

本文引用的文献

1
Prevalence, Risk Factors And Location Of Skip Metastasis In Papillary Thyroid Carcinoma: A Systematic Review And Meta-Analysis.甲状腺乳头状癌中跳跃转移的患病率、危险因素及位置:一项系统评价和荟萃分析
Cancer Manag Res. 2019 Sep 25;11:8721-8730. doi: 10.2147/CMAR.S200628. eCollection 2019.
2
Magnesemia: an independent risk factor of hypocalcemia after thyroidectomy.镁血症:甲状腺切除术后低钙血症的独立危险因素。
Cancer Manag Res. 2019 Sep 3;11:8135-8144. doi: 10.2147/CMAR.S218179. eCollection 2019.
3
The potential role of carbon nanoparticles-assisted biopsy for sentinel lymph nodes of incidental thyroid carcinoma.
预测高分化甲状腺癌患者生存结局的临床列线图
Thyroid. 2025 Apr;35(4):397-405. doi: 10.1089/thy.2024.0486. Epub 2025 Feb 14.
4
Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer.乳头状甲状腺癌中5-甲基胞嘧啶相关特征的综合分析
Sci Rep. 2025 Feb 5;15(1):4405. doi: 10.1038/s41598-025-88657-2.
5
Interpretable machine learning models for predicting skip metastasis in cN0 papillary thyroid cancer based on clinicopathological and elastography radiomics features.基于临床病理和弹性成像放射组学特征的可解释机器学习模型用于预测cN0乳头状甲状腺癌的跳跃转移
Front Oncol. 2025 Jan 7;14:1457660. doi: 10.3389/fonc.2024.1457660. eCollection 2024.
6
Single-center external validation and reconstruction of multiple predictive models for skip lateral lymph node metastasis in papillary thyroid carcinoma.单中心外部验证及多预测模型在甲状腺乳头状癌跳跃侧颈部淋巴结转移中的重建。
Front Endocrinol (Lausanne). 2024 Aug 23;15:1366679. doi: 10.3389/fendo.2024.1366679. eCollection 2024.
7
Prediction of bilateral thyroid carcinoma and lateral cervical lymph node metastasis in PTC patients with suspicious thyroid nodules.预测 PTC 患者伴可疑甲状腺结节时双侧甲状腺癌及颈侧区淋巴结转移。
Endocrine. 2024 Aug;85(2):803-810. doi: 10.1007/s12020-024-03775-7. Epub 2024 Mar 19.
8
A Nomogram Model to Predict Deep Vein Thrombosis Risk After Surgery in Patients with Hip Fractures.一种预测髋部骨折患者术后深静脉血栓形成风险的列线图模型。
Indian J Orthop. 2024 Jan 5;58(2):151-161. doi: 10.1007/s43465-023-01074-3. eCollection 2024 Feb.
9
m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma.m6A 阅读器 IGF2BP2 通过稳定 DPP4 促进甲状腺乳头状癌的淋巴转移。
Cancer Gene Ther. 2024 Feb;31(2):285-299. doi: 10.1038/s41417-023-00702-2. Epub 2023 Dec 15.
10
Risk factor analysis and prediction model for papillary thyroid carcinoma with lymph node metastasis.甲状腺乳头状癌伴淋巴结转移的危险因素分析及预测模型。
Front Endocrinol (Lausanne). 2023 Oct 30;14:1287593. doi: 10.3389/fendo.2023.1287593. eCollection 2023.
碳纳米颗粒辅助活检在偶发性甲状腺癌前哨淋巴结中的潜在作用。
Gland Surg. 2019 Aug;8(4):370-377. doi: 10.21037/gs.2019.07.08.
4
A Nomogram Predicting Microvascular Invasion Risk in BCLC 0/A Hepatocellular Carcinoma after Curative Resection.BCLC 0/A 期肝细胞癌根治性切除术后微血管侵犯风险的列线图预测模型。
Biomed Res Int. 2019 Jul 25;2019:9264137. doi: 10.1155/2019/9264137. eCollection 2019.
5
Clinical characteristics and disease-specific prognostic nomogram for primary gliosarcoma: a SEER population-based analysis.原发性胶质肉瘤的临床特征和疾病特异性预后列线图:一项基于 SEER 人群的分析。
Sci Rep. 2019 Jul 24;9(1):10744. doi: 10.1038/s41598-019-47211-7.
6
A Pre-operative Nomogram for Prediction of Lymph Node Metastasis in Bladder Urothelial Carcinoma.一种用于预测膀胱尿路上皮癌淋巴结转移的术前列线图。
Front Oncol. 2019 Jun 21;9:488. doi: 10.3389/fonc.2019.00488. eCollection 2019.
7
A Nomogram Predicting Lymph Node Metastasis in T1 Breast Cancer based on the Surveillance, Epidemiology, and End Results Program.基于监测、流行病学和最终结果计划的预测T1期乳腺癌淋巴结转移的列线图
J Cancer. 2019 May 27;10(11):2443-2449. doi: 10.7150/jca.30386. eCollection 2019.
8
Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.分析预测甲状腺乳头状癌颈淋巴结转移的风险因素:966 例患者研究。
BMC Cancer. 2019 Jun 25;19(1):622. doi: 10.1186/s12885-019-5835-6.
9
Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review.分化型甲状腺癌中跳跃性转移至侧颈淋巴结:一项系统评价
BMC Surg. 2019 Apr 24;18(Suppl 1):112. doi: 10.1186/s12893-018-0435-y.
10
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.甲状腺乳头状癌跳跃性转移和侧颈部淋巴结转移的危险因素。
Surgery. 2019 Jul;166(1):55-60. doi: 10.1016/j.surg.2019.01.025. Epub 2019 Mar 12.